Literature DB >> 9068139

Transthyretin Ile 122 and cardiac amyloidosis in African-Americans. 2 case reports.

D R Jacobson1, M Ittmann, J N Buxbaum, R Wieczorek, P D Gorevic.   

Abstract

Two cases of cardiac amyloidosis resulting from deposition of the Ile 122 variant of transthyretin in African-Americans are presented. These cases illustrate several typical features of this disorder, including electrocardiographic abnormalities and digoxin toxicity. Transthyretin Ile 122 is a common amyloidogenic variant in African-Americans (present as a heterozygous variant in 4% of this population); therefore, the diagnosis of transthyretin Ile 122 cardiac amyloidosis should be considered in African-Americans with unexplained restrictive cardiomyopathy or arrhythmias.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9068139      PMCID: PMC325397     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  27 in total

1.  Nomenclature and classification of amyloid and amyloidoses.

Authors:  G Husby
Journal:  J Intern Med       Date:  1992-12       Impact factor: 8.989

Review 2.  Genetic aspects of amyloidosis.

Authors:  D R Jacobson; J N Buxbaum
Journal:  Adv Hum Genet       Date:  1991

3.  Assessment of relative sensitivities of noninvasive tests for cardiac amyloidosis in documented cardiac amyloidosis.

Authors:  M Simons; J M Isner
Journal:  Am J Cardiol       Date:  1992-02-01       Impact factor: 2.778

4.  A specific test for transthyretin 122 (Val----Ile), based on PCR-primer-introduced restriction analysis (PCR-PIRA): confirmation of the gene frequency in blacks.

Authors:  D R Jacobson
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

5.  Liver transplantation as a treatment for familial amyloidotic polyneuropathy.

Authors:  M Skinner; W D Lewis; L A Jones; J Kasirsky; K Kane; S T Ju; R Jenkins; R H Falk; R W Simms; A S Cohen
Journal:  Ann Intern Med       Date:  1994-01-15       Impact factor: 25.391

6.  Senile cardiac amyloidosis associated with homozygosity for a transthyretin variant (ILE-122).

Authors:  W C Nichols; J J Liepnieks; E L Snyder; M D Benson
Journal:  J Lab Clin Med       Date:  1991-03

7.  A new transthyretin mutation associated with amyloidotic vitreous opacities. Asparagine for isoleucine at position 84.

Authors:  M Skinner; J Harding; I Skare; L A Jones; A S Cohen; A Milunsky; J Skare
Journal:  Ophthalmology       Date:  1992-04       Impact factor: 12.079

8.  Homozygosity for the transthyretin-Met30-gene in seven individuals with familial amyloidosis with polyneuropathy detected by restriction enzyme analysis of amplified genomic DNA sequences.

Authors:  G Holmgren; S Bergström; U Drugge; E Lundgren; C Nording-Sikström; O Sandgren; L Steen
Journal:  Clin Genet       Date:  1992-01       Impact factor: 4.438

9.  Amyloid localized to tenosynovium at carpal tunnel release. Immunohistochemical identification of amyloid type.

Authors:  R A Kyle; M A Gertz; R P Linke
Journal:  Am J Clin Pathol       Date:  1992-02       Impact factor: 2.493

10.  Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.

Authors:  G Cattoretti; M H Becker; G Key; M Duchrow; C Schlüter; J Galle; J Gerdes
Journal:  J Pathol       Date:  1992-12       Impact factor: 7.996

View more
  7 in total

1.  Homozygous transthyretin mutation in an African American Male.

Authors:  Eapen K Jacob; William D Edwards; Mark Zucker; Cyril D'Cruz; Surya V Seshan; Frank W Crow; W Edward Highsmith
Journal:  J Mol Diagn       Date:  2007-02       Impact factor: 5.568

2.  Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs.

Authors:  Steve Bourgault; Sungwook Choi; Joel N Buxbaum; Jeffery W Kelly; Joshua L Price; Natàlia Reixach
Journal:  Biochem Biophys Res Commun       Date:  2011-05-04       Impact factor: 3.575

3.  Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.

Authors:  J Malcom; O Arnold; Jonathan G Howlett; Anique Ducharme; Justin A Ezekowitz; Martin J Gardner; Nadia Giannetti; Haissam Haddad; George A Heckman; Debra Isaac; Philip Jong; Peter Liu; Elizabeth Mann; Robert S McKelvie; Gordon W Moe; Anna M Svendsen; Ross T Tsuyuki; Kelly O'Halloran; Heather J Ross; Errol J Sequeira; Michel White
Journal:  Can J Cardiol       Date:  2008-01       Impact factor: 5.223

Review 4.  Currents concepts on the immunopathology of amyloidosis.

Authors:  Anupama Bhat; Carlo Selmi; Stanley M Naguwa; Gurtej S Cheema; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

5.  Structure-based analysis of A19D, a variant of transthyretin involved in familial amyloid cardiomyopathy.

Authors:  Priscila Ferreira; Ricardo Sant'Anna; Oliveira Sant'Anna; Nathalia Varejão; Cinthia Lima; Shenia Novis; Renata V Barbosa; Concy M Caldeira; Franklin D Rumjanek; Salvador Ventura; Marcia W Cruz; Debora Foguel
Journal:  PLoS One       Date:  2013-12-17       Impact factor: 3.240

Review 6.  Clinical Characteristics and Treatment of Cardiomyopathies in Children.

Authors:  Jack F Price; Aamir Jeewa; Susan W Denfield
Journal:  Curr Cardiol Rev       Date:  2016

7.  Case 6/2017 - A 28-Year-Old Man with Anasarca And Restrictive Heart Disease.

Authors:  Desiderio Favarato; Luis Alberto Benvenuti
Journal:  Arq Bras Cardiol       Date:  2017-12       Impact factor: 2.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.